Study Of An Investigational Drug For Nonrelapsing Secondary Progressive Multiple Sclerosis
Seeking men and women aged 18-60 years old with secondary progressive multiple sclerosis (MS) with no relapses (nrSPMS) for a study of an investigational drug
Seeking men and women aged 18-60 years old with secondary progressive multiple sclerosis (MS) with no relapses (nrSPMS) for a study of an investigational drug
Seeking people aged 65 and older for a study of a digital screening tool for mild cognitive impairment using audio recordings.
Seeking people aged 12 and older with epilepsy who likely have primary generalized tonic-clonic seizure (PGTCS) for a study of an investigational drug.
Seeking men and women with multiple system atrophy and experience dizziness or feeling faint due to neurogenic orthostatic hypotension for a study of an investigational drug.
Seeking men and women aged 18 and older for a study of a device to help develop a Magnetic resonance imaging (MRI) technique to improve scans of the brain.
Seeking men and women over the age of 65 for a study of an investigational device to screen for cognitive impairment.
Seeking women and men who have started ocrelizumab treatment for their Multiple Sclerosis (MS) within the past month or people whose MS is being being treated with therapies other than ocrelizumab for a study looking at the incidence of cancer in the future.
This is a registry to collect medical record information from people living with Multiple Sclerosis (MS) to better understand the disease and develop new treatments
Seeking patients of the UMass Memorial Epilepsy Monitoring Unit aged 18 and older for a study of an investigational device to detect and predict epileptic seizures.
Seeking men and women aged 18 to 65 with relapsing multiple sclerosis who have either not started, or have discontinued treatment with a disease modifying therapy for a study of an investigational drug.
Seeking people aged 18-75 with Non-Active Secondary Progressive Multiple Sclerosis for a study of an investigational drug given as a nasal spray.
Seeking men and women with dystonia and essential tremor undergoing deep brain stimulation (DBS) for a study to better understand laryngeal dystonia (LD) and voice tremor (VT), which are neurological conditions causing abnormal voice and speech control.
Seeking men and women diagnosed with Multiple sclerosis (MS) within the past 2 years for a study of whether ocrelizumab (study drug) can be used for a period of time rather than permanently and still control your early relapsing MS disease activity.
Seeking men and women who have had a recent stroke or transient ischemic attach (TIA) often called a "mini-stroke" for a study of the benefits of using a continuous positive airway pressure (CPAP) machine while sleeping.
Seeking men and women with atrial fibrillation and a recent brain hemorrhage causing increased risk for stroke for a study of blood thinners to reduce risk of stroke.
Seeking men and women with multiple sclerosis (MS) that hasn't responded to previous treatment for a study of an experimental drug.
Seeking men and women whose doctor has recommended treatment for an acute ischemic stroke for a study collecting blood clots and medical information to better understand how to treat and prevent acute ischemic stroke.
Seeking men and women aged 50 and older who have had bleeding in the brain (brain hemorrhage) for a study comparing continuing or stopping statin drug use treatment on the risk of having another brain hemorrhage.
Seeking people who been diagnosed with Multiple Sclerosis (MS) or a similar immune disorder of the central nervous system or their immediate family members for a study to better understand what causes these diseases and perhaps improve treatment.
Seeking men and women with multiple sclerosis for a study of how common sleep apnea is and whether sleep apnea affects MS symptoms.
Seeking men and women with Amyotrophic Lateral Sclerosis (ALS) to participate in a research trial to test several different investigational treatments.
Seeking men and women whose multiple sclerosis has remained active despite treatment for a study comparing blood stem cell transplantation to other available treatments for multiple sclerosis.
Seeking men and women aged 18 and older who have been admitted to the hospital intensive care unit following a traumatic brain injury for a study of how care received in the hospital impacts long-term recovery.
Seeking men and women with relapsing multiple sclerosis whose doctors has decided to start treatment with clabridine tablets because other pills were not working well.
This study is enrolling men and women who have had a traumatic brain injury in order to compare outcomes when medical care is delivered based on either monitoring the pressure in the brain or monitoring both the pressure in the brain and the amount of oxygen in the brain.
Newly diagnosed (within 6 months) people with Multiple Sclerosis (MS) sought for a trial comparing "first line" (traditional) with "second line" (aggressive) treatments in preventing disability. This is a pragmatic trial which means that even though participants will be randomly assigned a treatment group, they and their doctor can change their treatment if needed.
Seeking men and women 18 years of age or older who have been diagnosed with a specific type brain aneurysm for study of the long term safety of an approved device (WEB®) intended to treat this issue.
Volunteers who are at risk for having heart disease, taking aspirin, and will be or have already undergone a cardiac catheterization sought for a study of how the body makes blood clots and its effect on the risk for heart attack and stroke.